COL11A1 and neoplasm: Validation of consistent expression of target genes and to exclude epitope masking due to the tertiary structure of the protein in individual tumor cells is critical, which may involve performing IHC of primary patient samples and evaluating gene expression at single cell level by re-analyzing appropriate scRNA-seq data sets as demonstrated in our validation of COL11A1.